Differential Immune Checkpoint Expression in CD4+ and CD4− NKT Cell Populations During Healthy Pregnancy
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26168022 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Matyas Meggyes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, Department of Medical Microbiology, University of Pecs, 7624 Pecs, Hungary. Hauptthemen laut MEDLINE: Natural Killer T-Cells, CD4-Positive T-Lymphocytes, Immune Checkpoint Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Pecs Medical School.
Abstract (Originalsprache)
This study investigated the expression of immune checkpoint molecules on CD4+ and CD4− NKT cell subpopulations throughout healthy pregnancy trimesters and in non-pregnant condition to understand their role in maternal–fetal immunotolerance. Using flow cytometry, we found that CD4− NKT cells significantly outnumbered CD4+ NKT cells in all investigated groups. In the case of the immune checkpoint molecules, PD-1 receptor expression was significantly lower in CD4− NKT cells compared to CD4+ counterpart cells only in non-pregnant women, while the PD-L1 ligand expression on CD4+ NKT cells significantly decreased in the third trimester. In contrast, LAG-3 and Galectin-3 expressions remained stable across all subsets and trimesters. For the TIGIT/CD226 axis, CD226 expression was significantly higher in CD4+ NKT cells in the third trimester and in non-pregnant women. The two ligands CD112 and CD155 were consistently lower on CD4− NKT cells across all groups. The activating receptor NKG2D was significantly higher on CD4− NKT cells in all examined cohorts. These findings suggest that CD4+ NKT cells tend towards a more tolerogenic phenotype, while CD4− NKT cells maintain a balanced cytotoxic potential with reduced immunoregulation function. The dynamic regulation of immune checkpoints on NKT cell subsets, particularly the downregulation of PD-L1 and CD226 in late pregnancy, highlights their fine-tuned role in balancing maternal–fetal immune tolerance with readiness for parturition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical School, Department of Medical Microbiology, University of Pecs, 7624 Pecs, Hungary.
- Institute of Geobotany/Plant Ecology, Martin-Luther-University, Große Steinstraße 79/80, D-06108 Halle (Saale), Germany.
- Medical School, Department of Obstetrics and Gynaecology, University of Pecs, 7624 Pecs, Hungary.
ORCID-Profile: Matyas Meggyes, Nagy U David, Laszlo Szereday
Förderung
- University of Pecs Medical School
Zitieren
APA
Meggyes, M., David, N. U., Mezosi, L., Vastag, F., Kevey, D., & Szereday, L. (2025). Differential Immune Checkpoint Expression in CD4+ and CD4− NKT Cell Populations During Healthy Pregnancy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26168022
Vancouver
Meggyes M, David NU, Mezosi L, Vastag F, Kevey D, Szereday L. Differential Immune Checkpoint Expression in CD4+ and CD4− NKT Cell Populations During Healthy Pregnancy. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26168022
BibTeX
@article{Meggyes2025,
author = {Meggyes, Matyas and David, Nagy U and Mezosi, Livia and Vastag, Fanni and Kevey, Dora and Szereday, Laszlo},
title = {Differential Immune Checkpoint Expression in CD4+ and CD4− NKT Cell Populations During Healthy Pregnancy},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26168022}
}
EUVIMED